Privacy Policy

 

Ceolia Pharmaceutical Co., Ltd. (hereinafter referred to as the Company) recognizes the importance of personal information, we will strive to protect personal information in accordance with the following policy.

1. While gathering any personal information, the company will clearly mention the purpose of gathering information to the providers and will follow legal and honest methods to accomplish the necessary objective.

2. We resolve for perfection in security measures to prevent, unauthorized access, disclosure, loss, manipulation, etc of personal information.

3. In order to comply with laws and regulations as well as the norms related to the protection of personal information, our company strives to continuously maintain and improve under the proper management system.

4. In-case of disclosure, manipulation or deletion of any personal Information, it would be confirmed and appropriate measures would be taken to maintain the accurate information.

5. The personal information will be provided to the affiliates or subcontractors in compliance with the information handling policy and within the scope of the purposes described below.

6. Other than the mentioned policy of information security, we adhere to other information security laws, like “Personal Information Protection Law (Law No. 57, 2003)”.

July 1, 2022.

Ceolia Pharma Co., Ltd.

Tetsuya Sugimoto

President and CEO

Regarding Handling of Personal Information

Purposes

The personal information would be shared within the scope of following purposes.
１．Use of personal information or retained personal data of doctors, dentists, pharmacist and other medical personnel for the following purposes

  • Offer and collect the information related to the appropriate usage of the medicines.
  • Offer and collect the information related to quality, safety and validity of the medicines.
  • Research and study of medical and pharmaceutical fields.
  • Offer, collect and examine medical and academic information.
  • Contact information and membership authentication of the Internet site for the medical personnel.
  • Request and implement clinical trial, post-marketing surveillance, etc.
  • Communicate and offer manufacturers and distributors, marketing vendors of medical products and other persons related to medical field etc.
  • Notify and report to Government.

 

２．The personal information would be used by users and enquirers.

  • Investigate, examine and consult the discussion and contact details
  • Offer and contacts manufacturers and distributors and related parties of medical products
  • Notify and report to Government

３．Use of personal information or retained personal data of manufacturers, distributors, executives and employees of other related trading companies, (Other business operations or related to the business activities), entities, organizations, agencies, etc. (No preference to private or public sector and corporate bodies)

  • Contacts related to other activities of business transactions or business operations.
  • Offer and collect the information related to the appropriate usage of the medicines.
  • Offer and collect the information related to quality, safety and validity of the medicines.
  • Offer, collect and examine medical and academic information.
  • Offer and contacts manufacturers and distributors and related parties of medical products.
  • Notify and report to Government.

Safety management of personal information

Necessary and appropriate measures are taken for safety management and prevention of disclosure, loss, manipulation, etc. of personal information.

Handling consignment of personal information

In-case of outsourcing complete or a part of personal information handling to a third party, it is necessary to conduct a rigorous investigation of that party. The safety management of entrusted personal information handling is achieved by conducting appropriate supervision.

Third party provision of personal information

Except in the cases permitted by Personal Information Protection Act, it is not allowed to provide the personal information to the third party without prior consent.

Disclosure and manipulation of personal information

The personal information is promptly respond to the request of disclosure of the personal information in-case if it is requested by the provider of the information. But the disclosure is not accepted unless the identity of the provider is confirmed. When there is any request from the providers for correction or manipulation of the information, the company will promptly respond to such requests after required investigation. But the request will not be accepted unless the identity of the provider is confirmed.

In-case of above mentioned requests or enquires regarding handling of personal information, please contact us on the following address.

[Contact information]
Ceolia Pharma Co., Ltd.
E.T.S. Muromachi building, 10th floor,
Nihonbashi 3-3-1, Chuo Ku, Tokyo - 103-0022
Tel : 03-3243-1135

Organizational Structure

The Company has appointed a personal information management in-charge to conduct proper management and continuous improvement of personal information.

Change of policy

The contents of this policy are subjected to change.

For the policy change will take effect from the time that was posted on the site, except if the site is separately determined.

Joint use of personal data

The personal data which the company shares jointly is as follows.

1. Personal data that is included in the medical database of Nihon Ultmarc INC.

The personal data is jointly used by the member companies that has entered into an agreement with Nihon Ultmarc INC.

Please visit the home page of Nihon Ultmarc INC. to see the personal data item, users and the purpose of using the data.